It has been shown that the expression of miR-17-92 cluster genes are increased in CD34+ cells in the early chronic phase of CML through the BCR-ABL-c-MYC-miR-17-92 pathway (Venturini et al., 2007). This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.